455 related articles for article (PubMed ID: 28130969)
41. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.
Shi SF; Wang SX; Jiang L; Lv JC; Liu LJ; Chen YQ; Zhu SN; Liu G; Zou WZ; Zhang H; Wang HY
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2175-84. PubMed ID: 21852672
[TBL] [Abstract][Full Text] [Related]
42. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
43. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
44. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
45. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
46. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
Puapatanakul P; Banjongjit A; Kanjanabuch T; Surintrspanont J; Iampenkhae K; Praditpornsilpa K; Eiam-Ong S; Boonpucknavig V
Am J Nephrol; 2023; 54(7-8):308-318. PubMed ID: 37429271
[TBL] [Abstract][Full Text] [Related]
48. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
49. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
50. Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
Shu D; Xu F; Su Z; Zhang J; Chen C; Zhang J; Ding X; Lv Y; Lin H; Huang P
BMC Nephrol; 2017 Jan; 18(1):11. PubMed ID: 28061828
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
52. Validation of the Oxford classification of IgA nephropathy.
Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
[TBL] [Abstract][Full Text] [Related]
53. [Application of the Oxford classification of IgA nephropathy to predict renal outcome].
Peng YH; Su Y; Zhao YJ; Lin CN; Sun GF; Li H; Yu Y; Huang QY; Ye W; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):102-7. PubMed ID: 23469800
[TBL] [Abstract][Full Text] [Related]
54. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function.
Tan M; Fang J; Xu Q; Zhang C; Zou G; Wang M; Li W
Ren Fail; 2019 Nov; 41(1):875-882. PubMed ID: 31517550
[No Abstract] [Full Text] [Related]
56. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
[TBL] [Abstract][Full Text] [Related]
57. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
[TBL] [Abstract][Full Text] [Related]
58. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
59. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S;
Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013
[TBL] [Abstract][Full Text] [Related]
60. Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies.
Zhang J; Chen GD; Qiu J; Liu GC; Chen LZ; Fu K; Wu ZX
BMC Nephrol; 2019 Dec; 20(1):446. PubMed ID: 31796001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
